Advancement of therapies for neuroprotection in multiple sclerosis

Modeling Axonal Degeneration Within the Anterior Visual System

(2008) Elliot M. Frohman et al.   ARCHIVES OF NEUROLOGY

Therapeutic potential of CB2 targeting in multiple sclerosis

(2008) Fabian Docagne et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection

(2008) David Azoulay et al.   JOURNAL OF NEUROIMMUNOLOGY

Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis

(2008) Tapas K. Makar et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status

(2008) Stephen G Waxman   Nature clinical practice. Neurology

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis

(2007) J. Ludovic Croxford et al.   JOURNAL OF NEUROIMMUNOLOGY